Cryobiopsy vs Forceps Biopsy for Lung Disease
(FROSTBITE-2 Trial)
Trial Summary
What is the purpose of this trial?
This trial compares a new method to a standard one for lung biopsies. It targets patients needing lung tissue samples, aiming to improve sample quality and reduce complications. The new method works by freezing and removing tissue, providing larger and higher-quality samples with a good safety and cost-benefit profile.
Research Team
Jeffrey Thiboutot, MD, MHS
Principal Investigator
Johns Hopkins University
Eligibility Criteria
This trial is for adults over 18 who need a lung biopsy as part of their usual care. It's not for those with bleeding disorders, severe heart or lung conditions, recent strokes or heart attacks, low platelet counts, or women who could be pregnant and won't test. People on certain blood thinners can't join.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Cryoprobe (Procedure)
- Forceps (Procedure)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
Theodore DeWeese
Johns Hopkins University
Chief Executive Officer since 2023
MD from an unspecified institution
Allen Kachalia
Johns Hopkins University
Chief Medical Officer since 2023
MD from an unspecified institution
Erbe USA Incorporated
Collaborator